BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19383573)

  • 1. [From the metabolic syndrome to the concept of global cardiometabolic risk].
    Nádas J; Jermendy G
    Orv Hetil; 2009 May; 150(18):821-9. PubMed ID: 19383573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events.
    Zarich SW
    Rev Cardiovasc Med; 2005; 6(4):194-205. PubMed ID: 16379015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic syndrome after pregnancy complicated with gestational diabetes: four-year follow-up].
    Madarász E; Tamás G; Tabák GA; Szalay J; Kerényi Z
    Orv Hetil; 2008 May; 149(18):831-8. PubMed ID: 18436511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of treating cardiometabolic risk factors in patients with type 2 diabetes.
    Barnett AH
    Diab Vasc Dis Res; 2008 Mar; 5(1):9-14. PubMed ID: 18398806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Following in mother's footsteps? Mother-daughter risks for insulin resistance and cardiovascular disease 15 years after gestational diabetes.
    Egeland GM; Meltzer SJ
    Diabet Med; 2010 Mar; 27(3):257-65. PubMed ID: 20536487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study.
    Smith JD; Borel AL; Nazare JA; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP
    J Clin Endocrinol Metab; 2012 May; 97(5):1517-25. PubMed ID: 22337910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
    Misra A; Khurana L
    Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey.
    Oladapo OO; Salako L; Sodiq O; Shoyinka K; Adedapo K; Falase AO
    Cardiovasc J Afr; 2010; 21(1):26-31. PubMed ID: 20224842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.
    O'Neill S; O'Driscoll L
    Obes Rev; 2015 Jan; 16(1):1-12. PubMed ID: 25407540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome: underdiagnosed and undertreated.
    Ripsin C
    South Med J; 2009 Dec; 102(12):1194-5. PubMed ID: 20016419
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The metabolic syndrome--clinical significance in 2011. Position statement of the Hungarian Diabetes Society, Metabolism Work Group].
    Barkai L; Halmos T; Hidvégi T; Jermendy G; Korányi L; Madácsy L; Pados G; Winkler G;
    Orv Hetil; 2011 Sep; 152(36):1450-8. PubMed ID: 21865147
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.